CIK 0001907685
CMRA Comera Life Sciences Holdings, Inc.
Insider trading from SEC Form 4. Last filing Feb 2, 2024. Close $0.00 on Oct 9, 2026, 0% from the 52-week low and 0% from the high.
In brief
Comera Life Sciences Holdings, Inc. (CMRA) has 16 SEC Form 4 filings on file from 15 insiders, the latest filed on Feb 2, 2024. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 open-market trade has been scored at CMRA. The newest: Michael Gerard Campbell (EVP & CFO) bought $708 of stock on Nov 27, 2023, filed Nov 28, 2023, scored 28 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Comera Life Sciences Holdings, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | Michael Gerard Campbell EVP & CFO buy | $708 10,000 shares | +40% | - |
Transactions
Every row filed, 25 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | Shameek Konar other | POpen-market purchase 12.0% Senior Secured Convertible Notesderivativeindirect: By Regolith Capital Investments L.P. | - | $112,500.00 | - | - | Feb 2, 2024 |
| Dec 29, 2023 | Shameek Konar other | POpen-market purchase Warrants to Purchase Common Stockderivativeindirect: By Regolith Capital Investments L.P. | +4,090,908 | $0.00 | $0 | 4,090,908 | Feb 2, 2024 |
| Dec 29, 2023 | George P Denny III other | POpen-market purchase 12.0% Senior Secured Convertible Notesderivativeindirect: By Denny Family Partners II, LLC | - | $107,622.00 | - | - | Jan 11, 2024 |
| Dec 29, 2023 | George P Denny III other | POpen-market purchase Warrants to Purchase Common Stockderivativeindirect: By Denny Family Partners II, LLC | +3,913,526 | $0.00 | $0 | 3,913,526 | Jan 11, 2024 |
| Dec 29, 2023 | Iaf, LLC other | POpen-market purchase 12.0% Senior Secured Convertible Notesderivative | - | $210,000.00 | - | - | Jan 5, 2024 |
| Dec 29, 2023 | Iaf, LLC other | POpen-market purchase Warrants to Purchase Common Stockderivative | +7,636,362 | $0.00 | $0 | 7,636,362 | Jan 5, 2024 |
| Dec 29, 2023 | Charles Cherington owner | POpen-market purchase 12.0% Senior Secured Convertible Notesderivative | - | $567,900.00 | - | - | Jan 3, 2024 |
| Dec 29, 2023 | Freebird Partners LP owner | POpen-market purchase Convertible Note Sharesderivative | +2,453,636 | $0.06 | $135k | 2,453,636 | Jan 3, 2024 |
| Dec 29, 2023 | Charles Cherington owner | POpen-market purchase Warrants to Purchase Common Stockderivative | +20,650,908 | $0.00 | $0 | 20,650,908 | Jan 3, 2024 |
| Dec 29, 2023 | Freebird Partners LP owner | POpen-market purchase Common Stock Purchase Warrantderivative | +4,907,272 | - | - | 7,362,005 | Jan 3, 2024 |
| Dec 27, 2023 | Charles Cherington owner | POpen-market purchase Series A Convertible Perpetual Preferred Stockderivativeindirect: By LLC | +3,896 | $500,000.00 | $1.9B | 3,896 | Jan 3, 2024 |
| Dec 29, 2023 | David Soane owner | POpen-market purchase 12% Senior Secured Convertible Notederivativeindirect: By Trust | +1,363,636 | $75,000.00 | $102B | 1,363,636 | Jan 3, 2024 |
| Dec 29, 2023 | David Soane owner | POpen-market purchase 12% Senior Secured Convertible Notederivativeindirect: By Trust | +1,363,636 | $75,000.00 | $102B | 1,363,636 | Jan 3, 2024 |
| Dec 29, 2023 | David Soane owner | POpen-market purchase Warrant (right to buy)derivativeindirect: By Trust | +2,727,272 | $0.00 | $0 | 2,727,272 | Jan 3, 2024 |
| Dec 29, 2023 | David Soane owner | POpen-market purchase Warrant (right to buy)derivativeindirect: By Trust | +2,727,272 | $0.00 | $0 | 2,727,272 | Jan 3, 2024 |
| Nov 27, 2023 | Michael Gerard Campbell EVP & CFO | POpen-market purchase Common Stock | +10,000 | $0.07 | $708 | 35,000 | Nov 28, 2023 |
| Nov 15, 2023 | William A. Wexler director | JOther Common Stock | +3,113 | $0.00 | $0 | 20,811 | Nov 17, 2023 |
| Nov 9, 2023 | Sirshendu Roopom Banerjee director | AGrant or award Stock Option (Right to Purchase)derivative | +122,487 | $0.00 | $0 | 122,487 | Nov 14, 2023 |
| Nov 9, 2023 | James Sherblom director | AGrant or award Stock Option (Right to Purchase)derivative | +103,643 | $0.00 | $0 | 103,643 | Nov 14, 2023 |
| Nov 9, 2023 | Kirsten Flowers director | AGrant or award Stock Option (Right to Purchase)derivative | +111,494 | $0.00 | $0 | 111,494 | Nov 14, 2023 |
| Nov 9, 2023 | Edward Aloysius Sullivan Jr. director | AGrant or award Stock Option (Right to Purchase)derivative | +127,198 | $0.00 | $0 | 127,198 | Nov 14, 2023 |
| Nov 9, 2023 | William A. Wexler director | AGrant or award Stock Option (Right to Purchase)derivative | +75,376 | $0.00 | $0 | 75,376 | Nov 14, 2023 |
| Nov 7, 2023 | Dorothy J Clarke director | AGrant or award Stock Option (Right to Purchasederivative | +14,200 | $0.00 | $0 | 14,200 | Nov 13, 2023 |
| Oct 14, 2023 | Janice McCourt Chief Business Officer | AGrant or award Stock Option (Right to Purchase)derivative | +20,000 | $0.00 | $0 | 20,000 | Oct 16, 2023 |
| Oct 14, 2023 | Neal Muni EVP & COO | AGrant or award Stock Option (Right to Purchase)derivative | +60,000 | $0.00 | $0 | 60,000 | Oct 16, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Sirshendu Roopom Banerjeedirector
- Michael Gerard CampbellEVP & CFO
- Charles Cheringtonowner
- Dorothy J Clarkedirector, officer
- George P Denny IIIother
- Kirsten Flowersdirector
- Freebird Partners LPowner
- Iaf, LLCother
- Shameek Konardirector, other
- Janice McCourtChief Business Officer
- Neal MuniEVP & COO
- James Sherblomdirector
- David Soaneowner
- Edward Aloysius Sullivan Jr.director
- William A. Wexlerdirector
Questions about CMRA
Answered from the filings on this page, as of the latest one.
Are insiders buying CMRA?
No. In the last 90 days no insider at Comera Life Sciences Holdings, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CMRA on the open market?
Michael Gerard Campbell (EVP & CFO) bought $708 of CMRA on Nov 27, 2023 and filed the Form 4 on Nov 28, 2023. InsiderTell scored 28 (weak).
How many insiders file Form 4 at Comera Life Sciences Holdings, Inc.?
15 people have filed a Form 4 at Comera Life Sciences Holdings, Inc., among them Sirshendu Roopom Banerjee (director), Michael Gerard Campbell (EVP & CFO), Charles Cherington (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.